MCY Mercury General (MCY) Insider Trading, Ownership & Congress Trades
Insurance · Fire, marine & casualty insurance · CIK 0000064996
Activist 13D
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
What the filings say about MCY
Activist stakes (13D), 180 days
1 filing
Largest: 35.3% of the class
Mercury General insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
No insider purchases or sales are on record for MERCURY GENERAL CORP in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 18.1% of the 3,053 shares held after it.
- No other insider bought within 30 days.
Insider activity: Director Braunegg George Gwyer bought about $49.9K of MCY on Dec 10, 2025.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 99.8% of the 15,025 shares held after it.
- 1 other insider bought within 30 days.
Insider activity: President & COO Joseph Victor George bought about $899.2K of MCY on May 23, 2025, the largest insider purchase at the company on our record; 1 other insider bought within 30 days.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 100.0% of the 1,500 shares held after it.
- 1 other insider bought within 30 days.
Insider activity: See Remarks Zhang Ximeng Simon bought about $92.9K of MCY on May 16, 2025, the largest insider purchase at the company on our record; 1 other insider bought within 30 days.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 8.1% of the 680 shares held after it.
- No other insider bought within 30 days.
Insider activity: President of AIS subsidiary Ribisi Mark Allan bought about $3.6K of MCY on Jan 7, 2025, the largest insider purchase at the company since 2023.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- No other insider sold within 30 days.
Insider activity: VP/Chief Human Capital Officer Sullivan Heidi C. sold about $83.2K of MCY on Dec 3, 2024, the largest insider sale at the company on our record.12 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
+17.5% year over year
more than 66% of Insurance
Margin
1828.0% net margin
the highest in Insurance
Buybacks
no share repurchases reported
Short interest
5.5% of the float short (float per yahoo 2026-10-26) · 4.6 days to cover · settled 2026-09-30
below 53% of Insurance
The situation: each line is one rule over one dataset
Vicky Wai Yee Joseph disclosed a 5%+ stake (35.3%) in the last six months.
What changed in the last 30 days
Sep 30Vicky Wai Yee Joseph filed a 13D for 35.3%
Watch MCY
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+30.1%12M
Insider buy13D/G stake
Indexed to 100, dividend-adjusted, not a price chart.
When a name files heavily, the largest trades are drawn first.
Who owns MCY: institutional holders (13F)
13F holdings, latest reported quarter
SEC 13F
No reported 13F holders
No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.
Congress trades in MCY
No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.
Activist and 5% holders (13D/13G)
13D: intends to influence · 13G: passive
Vicky Wai Yee Joseph
Activist 13D · 2026-09-30
35.3%
MCY planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
Executive pay vs shareholder return · Gabriel Tirador
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$5.6M
$7.6M
$2.8M
+113%
+134%
2024
$3.7M
$4.3M
$2.4M
+48%
+113%
2023
$1.7M
$1.7M
$1.2M
-19%
+57%
2022
$1.3M
$1.3M
$838.2K
-28%
+42%
2021
$1.7M
$1.7M
$1.0M
+6%
+19%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
An activist crossed the 5% line with declared intent.
Each figure here is a federal filing, dated the day it went public, so you can test what was knowable then.
MCY financials
Revenue growth
+17.5%
XBRL, annual
Net margin
1828.0%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$6.3B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM MCY
| FY Dec 2025 | $6.0B |
| FY Dec 2024 | $5.5B |
| FY Dec 2023 | $4.6B |
| FY Dec 2022 | $3.6B |
| FY Dec 2021 | $4.0B |
| Jun 2026 | $1.7B |
| Mar 2026 | $1.5B |
| Dec 2025 | $1.5B |
| Sep 2025 | $1.6B |
| Jun 2025 | $1.5B |
| Mar 2025 | $1.4B |
| Dec 2024 | $1.4B |
| Sep 2024 | $1.5B |
At each fiscal year end
Single quarter
Net margin, TTM
+14.8%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM MCY
| FY Dec 2025 | +9.0% |
| FY Dec 2024 | +8.5% |
| FY Dec 2023 | +2.1% |
| FY Dec 2022 | -14.1% |
| FY Dec 2021 | +6.2% |
| Jun 2026 | +15.7% |
| Mar 2026 | +12.4% |
| Dec 2025 | +13.2% |
| Sep 2025 | +17.7% |
| Jun 2025 | +11.3% |
| Mar 2025 | -7.8% |
| Dec 2024 | +7.4% |
| Sep 2024 | +15.1% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$1.3B
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM MCY
| FY Dec 2025 | $1.0B |
| FY Dec 2024 | $991.0M |
| FY Dec 2023 | $416.2M |
| FY Dec 2022 | $317.1M |
| FY Dec 2021 | $460.1M |
| Jun 2026 | $201.6M |
| Mar 2026 | $308.8M |
| Dec 2025 | $273.9M |
| Sep 2025 | $479.5M |
| Jun 2025 | $357.2M |
| Mar 2025 | -$81.9M |
| Dec 2024 | $236.0M |
| Sep 2024 | $306.2M |
At each fiscal year end
Single quarter
Debt to equity
0.33x
long-term debt only, 2026-06-30; equity 2026-06-30
Debt to equity MCY
| FY Dec 2025 | 0.24x |
| FY Dec 2024 | 0.30x |
| FY Dec 2023 | 0.37x |
| FY Dec 2022 | 0.26x |
| FY Dec 2021 | 0.18x |
| Jun 2026 | 0.33x |
| Mar 2026 | 0.22x |
| Dec 2025 | 0.24x |
| Sep 2025 | 0.26x |
| Jun 2025 | 0.29x |
| Mar 2025 | 0.32x |
| Dec 2024 | 0.30x |
| Sep 2024 | 0.31x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
1.41x
TTM operating cash flow over long-term debt only, 2026-06-30
Cash flow to debt MCY
| FY Dec 2025 | 1.89x |
| FY Dec 2024 | 1.80x |
| FY Dec 2023 | 0.79x |
| FY Dec 2022 | 0.88x |
| FY Dec 2021 | 1.34x |
| Jun 2026 | 1.41x |
| Mar 2026 | 2.58x |
| Dec 2025 | 1.89x |
| Sep 2025 | 1.82x |
| Jun 2025 | 1.51x |
| Mar 2025 | 1.35x |
| Dec 2024 | 1.80x |
| Sep 2024 | 1.76x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+39.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity MCY
| FY Dec 2025 | +24.8% |
| FY Dec 2024 | +26.8% |
| FY Dec 2023 | +6.3% |
| FY Dec 2022 | -28.0% |
| FY Dec 2021 | +11.9% |
| Jun 2026 | +39.0% |
| Mar 2026 | +38.1% |
| Dec 2025 | +24.8% |
| Sep 2025 | +21.5% |
| Jun 2025 | +21.6% |
| Mar 2025 | +16.7% |
| Dec 2024 | +26.8% |
| Sep 2024 | +34.5% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+9.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets MCY
| FY Dec 2025 | +6.1% |
| FY Dec 2024 | +6.1% |
| FY Dec 2023 | +1.4% |
| FY Dec 2022 | -7.7% |
| FY Dec 2021 | +3.8% |
| Jun 2026 | +9.5% |
| Mar 2026 | +8.9% |
| Dec 2025 | +6.1% |
| Sep 2025 | +5.0% |
| Jun 2025 | +4.6% |
| Mar 2025 | +3.5% |
| Dec 2024 | +6.1% |
| Sep 2024 | +7.4% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital MCY
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed MCY
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
6.01x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing MCY
| FY Dec 2025 | 9.63x |
| FY Dec 2024 | 7.87x |
| FY Dec 2023 | 21.44x |
| FY Dec 2022 | n/a |
| FY Dec 2021 | 11.87x |
| Jun 2026 | 6.30x |
| Mar 2026 | 5.81x |
| Dec 2025 | 9.63x |
| Sep 2025 | 10.69x |
| Jun 2025 | 9.57x |
| Mar 2025 | 10.83x |
| Dec 2024 | 7.87x |
| Sep 2024 | 6.24x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no cash line filed
Enterprise value MCY
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+22.4%
TTM free cash flow over market value at close 2026-10-26
FCF yield MCY
| FY Dec 2025 | +19.7% |
| FY Dec 2024 | +26.9% |
| FY Dec 2023 | +20.1% |
| FY Dec 2022 | +16.7% |
| FY Dec 2021 | +15.7% |
| Jun 2026 | +21.4% |
| Mar 2026 | +29.1% |
| Dec 2025 | +19.7% |
| Sep 2025 | +21.1% |
| Jun 2025 | +21.9% |
| Mar 2025 | +23.5% |
| Dec 2024 | +26.9% |
| Sep 2024 | +27.8% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.04x
P/E over trailing EPS growth of 140%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing MCY
| FY Dec 2025 | 0.62x |
| FY Dec 2024 | 0.02x |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Jun 2026 | 0.04x |
| Mar 2026 | 0.03x |
| Dec 2025 | 0.62x |
| Sep 2025 | n/a |
| Jun 2025 | 0.43x |
| Mar 2025 | 0.33x |
| Dec 2024 | 0.02x |
| Sep 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $6.0B | $5.5B | $4.6B | $3.6B |
| Net income | $541.1M | $468.0M | $96.3M | -$512.7M |
| EPS (diluted) | 9.77 | 8.45 | 1.74 | -9.26 |
| Operating cash flow | $1.1B | $1.0B | $453.0M | $352.6M |
| Long-term debt | $574.5M | $575.0M | $575.0M | $400.0M |
| Dividends paid | $70.3M | $70.3M | $70.3M | $105.5M |
SEC XBRL, fiscal years, as known on 2026-10-28
MCY Stock Sonar score 4/7 axes
Find similar shapesCompareMCY ranks highest on profitability (92nd percentile) and growth (66th), and lowest on risk and compliance (59th), among Insurance peers.
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
MCY filings, in plain words
Read the full summary
1 activist Schedule 13D filing in the last 180 days declared an intent to influence the company, the largest for 35.3% of the class. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
